Stem Cell Related Stocks Spiking on Reports Obama to Lift 8-Yr Ban on Embryonic Research (STEM, CYTX, PSTI, ASTM, GERN)
Any stock related to stem cell research is surging today following rumors that President Obama is expected to issue an executive order lifting an 8-year ban on embryonic stem cell research.
StemCells (Nasdaq: STEM) is leading the group higher, up about 18% from Friday's close. The stock most recently traded at $2.49. Elsewhere in the sector: Cytori Therapeutics (Nasdaq: CYTX) up 10.4% to $4.25, Pluristem Therapeutics (Nasdaq: PSTI) up 14.7% to $1.33 and Aastrom Biosciences (Nasdaq: ASTM) is up 12.6% to $0.58. Meanwhile, recent high-flyer Geron (Nasdaq: GERN) is only modestly higher today, currently up 3.8% to $6.62.
Related Categories
Insiders' BlogMomentum Movers
Stocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
